Floatz logo

Cartemis-1

Allogeneic Stem Cell Transplantation

Fundación Pública Andaluza para la gestión de la Investigación en SevillaPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Allogeneic Stem Cell Transplantation cohort.

Asset / SponsorPhaseRating
Bisantrene
Sheba Medical Center
Phase 2B
Ruxolitinib
Massachusetts General Hospital
Phase 2CCC
Interferon Gamma-1B
Sawa Ito, MD
Early Phase 1CC
Siremadlin
Novartis Pharmaceuticals
Phase 1/2CC

Same molecule, other indications

Cartemis-1 is also rated in:

plasma cell myelomaDormant
CC
Indicative ·
40 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →